For many people living with depression, anxiety, obsessive-compulsive disorder (OCD), or other mental health conditions, treatment begins with medication. While medication can be an important part of care, finding the right option is not always straightforward.

It is common for patients to spend months—or even years—adjusting dosages, switching prescriptions, or trying different combinations before finding meaningful improvement. This process is not a reflection of the patient’s effort or the physician’s expertise. Rather, it reflects the reality that every brain functions differently.

Computational brain mapping offers a different starting point.

Instead of relying primarily on symptom observation and medication response over time, Neurotherapeutix begins by evaluating how brain networks communicate.

Using advanced functional imaging and patented computational brain mapping, our team develops individualized treatment plans designed around each patient’s unique connectivity patterns.

This information can then be used to guide fMRI-guided TMS therapy and other treatment decisions, creating a more personalized path forward for individuals who feel stuck in a cycle of trial and error.

When medication becomes a process of elimination

Medication remains one of the most common treatments for depression and other mental health conditions.

For many individuals, it can provide meaningful symptom relief and improve quality of life.

However, medication management is often a process of refinement rather than immediate precision.

How medication management typically works

When a patient begins treatment, clinicians make recommendations based on symptoms, diagnosis, medical history, and clinical experience.

From there, treatment often involves:

• Starting a medication
• Monitoring response
• Adjusting dosage
• Evaluating side effects
• Trying alternatives when necessary

Because individuals respond differently to medications, it can take time to determine which option is the best fit.

Why it can take months—or years—to find the right fit

Mental health medications typically require several weeks before their full effects can be evaluated.

If symptoms do not improve, adjustments may be needed. Sometimes the medication works partially. Sometimes side effects become problematic. Sometimes another medication is added or substituted.

Over time, this process may involve multiple treatment attempts.

For patients who have already spent months or years navigating medication changes, the experience can become frustrating and emotionally exhausting.

For example, according to the National Institute of Mental Health, major depression affects millions of adults each year, and many individuals require multiple treatment attempts before finding an approach that provides meaningful symptom improvement.

This reality helps explain why medication management can become a lengthy process of adjustment and observation rather than a straightforward path to relief.

What “treatment-resistant” actually means

The term treatment-resistant depression generally refers to depression that has not adequately improved after multiple appropriate treatment attempts.

This does not mean a person cannot improve.

Instead, it often indicates that additional treatment approaches may be needed.

For many individuals seeking treatment for depression, persistent symptoms despite medication can become the reason they begin exploring alternatives such as functional brain imaging and fMRI-guided TMS therapy.

What brain mapping adds to the picture

Computational brain mapping is not a replacement for medication.

Rather, it provides an additional layer of information that can help clinicians better understand how a patient’s brain networks function.

Instead of focusing solely on symptoms, brain mapping evaluates the communication patterns occurring beneath those symptoms.

How fMRI-based imaging identifies functional connectivity patterns

At Neurotherapeutix, the process begins with patented computational brain mapping supported by advanced rsfMRI imaging.

Resting-state functional MRI measures blood oxygen level-dependent (BOLD) signals while the brain is at rest. These signals help reveal how different regions of the brain communicate within larger functional networks.

Rather than examining brain anatomy alone, the imaging evaluates functional connectivity—the relationships between neural systems involved in mood regulation, emotional processing, cognition, attention, and behavior.

What the data shows about individual brain differences

Two people may receive the same diagnosis while experiencing very different underlying network patterns.

One patient with depression may demonstrate connectivity changes involving emotional regulation circuits. Another may show disruptions involving cognitive control networks.

These differences help explain why individuals can respond differently to the same treatment.

Computational brain mapping allows clinicians to move beyond diagnosis alone and evaluate how a specific patient’s brain functions.

Why one-size-fits-all approaches may miss the mark

Traditional treatment approaches often begin with what is most likely to help based on population-level data.

Computational brain mapping starts with information about the individual.

This does not eliminate clinical judgment or replace other forms of treatment. Instead, it provides additional insight that may support more personalized decision-making.

From imaging to treatment planning

Collecting imaging data is only the beginning.

The value comes from how that information is translated into individualized treatment planning.

How rsfMRI findings inform stimulation targeting

After imaging is completed, Neurotherapeutix’s patented computational brain mapping platform analyzes functional connectivity patterns throughout the brain.

This analysis helps identify:

• Underactive networks
• Overactive networks
• Connectivity disruptions
• Neural circuits associated with symptoms

The goal is to understand how the patient’s brain networks communicate and where intervention may be most appropriate.

Targeting circuits tied to a patient’s specific symptoms

Once connectivity patterns have been analyzed, clinicians can use that information to help guide treatment planning.

For patients pursuing fMRI-guided TMS therapy, imaging data helps identify individualized stimulation targets based on network function rather than generalized positioning methods.

This approach recognizes that symptoms arise from neural circuits, not simply diagnoses.

How the approach differs from generalized anatomical landmarks

Standard TMS therapy protocols often rely on anatomical landmarks to determine stimulation locations.

Neurotherapeutix takes a different approach.

Using computational brain mapping and rsfMRI findings, clinicians evaluate where symptom-related networks are functioning within that patient’s brain before treatment begins.

This allows for individualized targeting based on functional connectivity rather than solely on anatomical assumptions.

What this means for the treatment timeline

One of the most common questions patients ask is whether brain mapping prolongs the treatment process.

The answer depends on how the timeline is measured.

Consultation and computational brain mapping before treatment begins

An fMRI-guided approach involves additional evaluation before treatment starts.

Patients first complete consultations, imaging, and computational analysis before individualized treatment planning occurs.

This requires more upfront assessment than simply beginning a medication trial.

Ongoing monitoring and targeting adjustments

The additional information gathered at the beginning may help support more informed treatment decisions moving forward.

Rather than relying exclusively on symptom response to guide adjustments, clinicians can incorporate connectivity data and individualized treatment planning into the decision-making process.

When to consider this approach

Many patients explore brain mapping after:

• Multiple medication trials
• Partial improvement from medications
• Persistent symptoms
• Previous standard TMS therapy
• Interest in a more personalized treatment strategy

For these individuals, understanding how their brain networks function may provide useful information when considering next steps.

Taking a closer look at your brain

If you have spent years navigating medication changes, dosage adjustments, or treatment approaches that did not provide the improvement you hoped for, it may feel as though you have run out of options.

In reality, you may simply need more information.

Computational brain mapping offers a way to evaluate how your brain networks function before making treatment decisions. At Neurotherapeutix, this information helps guide individualized care using advanced functional imaging, connectivity analysis, and fMRI-guided TMS therapy.

As the only clinical practice in the United States offering patented fMRI-guided TMS therapy and computational brain mapping, Neurotherapeutix provides a uniquely personalized approach designed around how your brain actually functions.

If you are interested in learning whether this approach may be appropriate for you, request an appointment to speak with our team.

Frequently asked questions

How is computational brain mapping different from a standard psychiatric evaluation?

A standard psychiatric evaluation focuses on symptoms, medical history, treatment history, and clinical assessment.

Computational brain mapping adds objective functional imaging data that helps clinicians evaluate how brain networks communicate and how those patterns may relate to symptoms.

Can computational brain mapping be used alongside medication?

Yes. Computational brain mapping does not replace medication. In many cases, it may be used alongside medication management, psychotherapy, or other treatment approaches as part of a comprehensive treatment plan.

Is fMRI-guided TMS therapy right for me if I’ve tried antidepressants without success?

It may be appropriate for some individuals who have not experienced adequate improvement from medication alone. Eligibility is determined through a clinical evaluation that considers symptoms, treatment history, and overall health.

Does Neurotherapeutix accept insurance?

Neurotherapeutix is a private-pay practice. We do not submit claims, communicate with insurance companies, or manage reimbursement requests on behalf of patients. However, we provide visit documentation, clinical records, and billing information for patients who choose to pursue reimbursement independently.

How do I get started?

The first step is a consultation. During the evaluation process, clinicians review your symptoms, treatment history, and goals to determine whether computational brain mapping and fMRI-guided TMS therapy may be appropriate for your needs.

Additional answers to common questions can also be found in our FAQ resources.

The effectiveness of brain stimulation depends on more than the stimulation itself. It also depends on where that stimulation is delivered.

Standard transcranial magnetic stimulation (TMS) therapy and fMRI-guided TMS therapy use the same non-invasive technology, but they approach treatment planning very differently.

A standard approach relies on fixed anatomical landmarks based on population averages, whereas an individualized approach uses each patient’s functional brain imaging and connectivity data to identify person‑specific treatment targets.

Understanding that distinction can help answer an important question: Why does precision matter?

At Neurotherapeutix, our approach begins with fMRI-guided TMS therapy, using functional connectivity data to guide individualized treatment planning.

As the only clinical practice in the United States offering patented fMRI-guided TMS therapy and computational brain mapping, we believe understanding where stimulation is delivered is just as important as the stimulation itself.

What is standard TMS therapy and how does it work?

Standard TMS therapy has helped expand access to non-invasive brain stimulation and has become an established treatment option for several mental health conditions.

According to the National Institute of Mental Health, TMS therapy uses magnetic pulses to stimulate specific areas of the brain involved in mood, cognition, and emotional regulation. It is commonly used when symptoms have not adequately improved with first-line treatments.

Understanding how standard TMS therapy works provides an important foundation for understanding how fMRI-guided approaches differ.

The mechanism: magnetic pulses and cortical stimulation

TMS therapy uses a magnetic coil positioned against the scalp to generate focused magnetic pulses.

These pulses pass through the skull and influence activity within targeted brain circuits. Over time, repeated stimulation may help support neuroplasticity, the brain’s ability to strengthen and reorganize neural connections.

Patients remain awake during treatment and can typically return to normal daily activities afterward.

Understanding how TMS therapy works provides useful context for comparing standard and connectivity-guided approaches.

How targets are selected in standard protocols

Most standard TMS therapy protocols identify treatment targets using scalp measurements and generalized anatomical landmarks.

For example, clinicians may approximate a stimulation site in the dorsolateral prefrontal cortex using scalp measurements or established positioning formulas. These methods are widely used and supported by clinical research, but they rely on external head measurements and group‑average data rather than the patient’s own brain anatomy, so the actual stimulation site can be substantially off and may not even fall fully within the true dorsolateral prefrontal region.

In practice, this means a fixed anatomical spot on the scalp is treated as if it reliably corresponds to the intended cortical target, even though it does not guarantee that stimulation reaches the same brain region or functional network in every patient..

The challenge is that both brain structure and connectivity can differ from person to person, so a ‘standard’ scalp location can map to different underlying tissue and network organization across patients. This variability is one reason Neurotherapeutix focuses on fMRI‑guided, personalized targeting that is based on each patient’s own brain networks rather than generalized anatomical assumptions.

What FDA clearance for standard TMS therapy covers

FDA-cleared TMS therapy protocols have demonstrated effectiveness for several conditions and have helped expand access to non-invasive brain stimulation.

Today, repetitive transcranial magnetic stimulation (rTMS) is FDA-cleared for:

• Treatment-resistant depression
• Obsessive-compulsive disorder (OCD)
• Migraines
• Anxiety symptoms associated with depression
• Smoking dependence

However, TMS therapy does not produce the same therapeutic effects as electroconvulsive therapy (ECT), and it is not approved for children younger than 15 years old.

These clearances are based on standardized treatment approaches that have helped many patients.

The question is not whether standard TMS therapy works. It clearly can.

The question is whether a more individualized understanding of brain connectivity may help improve how treatment targets are selected.

What “fMRI-guided” means in practice

The term “fMRI-guided” refers to the use of functional magnetic resonance imaging (fMRI) to help determine where stimulation should be delivered.

Instead of relying solely on anatomical estimates, clinicians evaluate how brain networks communicate and use that information to guide treatment planning.

This is where Neurotherapeutix differs from traditional TMS providers.

Resting-state fMRI and functional connectivity mapping

At Neurotherapeutix, treatment begins with advanced imaging.

Resting-state functional MRI (rsfMRI) measures blood oxygen level-dependent (BOLD) signals while the brain is at rest. These signals help reveal how different brain regions communicate within larger functional networks.

Rather than simply identifying where structures are located, rsfMRI helps clinicians understand how neural systems interact.

This information serves as the foundation of our patented computational brain mapping process, which analyzes functional connectivity patterns across the brain to identify individualized treatment targets.

From imaging to individualized targeting coordinates

Once imaging data is collected, Neurotherapeutix’s patented computational brain mapping platform performs advanced analysis of connectivity patterns throughout the brain.

Clinicians can identify:

• Underactive networks
• Overactive networks
• Disrupted communication pathways
• Connectivity patterns associated with symptoms

This information helps determine individualized stimulation targets based on the patient’s own functional network architecture.

Rather than asking, “Where is the target usually located?” the question becomes, “Where is the target located in this particular brain?”

Why anatomical landmarks and functional networks don’t always match

Brain anatomy may look similar between individuals, but functional connectivity can vary significantly.

Research on connectivity-guided neuromodulation has shown that two patients with the same diagnosis may exhibit different network-level patterns that contribute to their symptoms.

This means that a generalized anatomical location may not always correspond to the same functional target from one person to the next.

The goal of fMRI-guided TMS therapy is to reduce that uncertainty by incorporating patient-specific network information into treatment planning.

Comparing the two approaches side by side

Both standard TMS therapy and fMRI-guided TMS therapy use magnetic stimulation. The primary difference lies in how treatment targets are selected.

Targeting method: anatomical estimate vs. functional network data

Standard TMS therapy identifies targets based on generalized positioning techniques.

fMRI-guided TMS therapy uses each patient’s connectivity patterns to identify stimulation targets based on how their brain networks function.

Role of pre-treatment imaging

Most standard protocols do not require functional imaging before treatment.

At Neurotherapeutix, advanced imaging is the first step in the treatment process because it provides the data used for computational brain mapping and individualized treatment planning.

Understanding the differences between rsfMRI and SPECT imaging can help clarify why Neurotherapeutix relies on functional connectivity analysis when developing individualized treatment plans.

How treatment planning differs

Standard approaches focus on applying an established protocol.

fMRI-guided treatment planning begins with understanding the individual’s brain network architecture before determining where stimulation should be delivered.

Monitoring and adjustment during treatment

Both approaches involve ongoing clinical monitoring.

However, fMRI-guided treatment planning provides a more detailed understanding of the underlying network targets being addressed throughout care.

Why precision in targeting matters for outcomes

Brain stimulation is ultimately about influencing neural circuits.

The more accurately those circuits can be identified, the more precisely treatment can be directed.

Individual differences in brain network architecture

No two brains are wired the same way.

While patients may share diagnoses such as depression, anxiety, or OCD, the specific connectivity patterns contributing to symptoms can vary significantly.

This variation is one reason personalized treatment planning has become an area of increasing interest within neuroscience and psychiatry.

What happens when stimulation misses the intended circuit

If stimulation is delivered to a location that does not correspond to the intended functional network, treatment may still influence the brain, but not necessarily the circuit most closely associated with symptoms.

This does not mean standard TMS therapy is ineffective.

It means there may be value in understanding individual network architecture before selecting treatment targets.

How personalized targeting may improve the signal-to-noise ratio

One way to think about individualized targeting is through signal-to-noise ratio.

The goal is to maximize stimulation of the intended network while minimizing unnecessary variability.

By incorporating functional connectivity data into planning, clinicians can deliver stimulation with greater specificity and less reliance on generalized assumptions.

Who may benefit most from fMRI-guided TMS therapy?

Not every patient arrives at treatment for the same reason.

Some individuals are exploring TMS therapy for the first time. Others have already tried medications, psychotherapy, or even standard TMS therapy without achieving their desired results.

Those who haven’t responded to standard TMS therapy

Some patients seek evaluation after completing standard TMS therapy elsewhere.

In these situations, individualized connectivity analysis may provide additional information about treatment targets and network-level contributors to symptoms.

Complex presentations with overlapping conditions

Many patients experience more than one condition at the same time.

For example:

• Depression and anxiety
• PTSD and depression
• OCD and anxiety
• Cognitive symptoms alongside mood concerns

These overlapping presentations may involve multiple interacting networks rather than a single isolated circuit.

People who want a data-informed approach from the start

Some individuals simply prefer a more individualized approach from the beginning.

Rather than relying on generalized positioning methods, they want treatment planning informed by functional imaging and patient-specific connectivity data.

This is particularly common among individuals seeking treatment for depression who want a deeper understanding of how their symptoms may relate to underlying brain network activity before beginning therapy.

The case for knowing where you’re stimulating

The conversation about TMS therapy often centers on whether brain stimulation works.

A more useful question may be: How do you decide where stimulation should be delivered?

Standard TMS therapy and fMRI-guided TMS therapy share the same core technology. The difference is the amount of information used to guide treatment planning.

Our expert team believes understanding your brain’s unique connectivity patterns provides an opportunity to move beyond generalized targeting and toward individualized care.

As the only clinical practice in the United States offering patented fMRI-guided TMS therapy and computational brain mapping, Neurotherapeutix combines functional imaging, connectivity analysis, and individualized targeting to create treatment plans based on how each patient’s brain networks actually function.

If you would like to discuss whether fMRI-guided TMS therapy may be appropriate for your needs, request an appointment with our team.

Frequently asked questions

Is fMRI-guided TMS therapy the same as standard TMS therapy?

No. While both approaches use magnetic stimulation to influence brain activity, the primary difference is how treatment targets are selected.

Standard TMS therapy typically relies on anatomical landmarks to approximate where to stimulate, while fMRI-guided TMS therapy incorporates each patient’s individual functional connectivity data and computational analysis into treatment planning.

Does fMRI guidance mean the treatment takes longer?

The TMS therapy sessions themselves are generally similar. However, fMRI-guided treatment includes additional imaging and computational analysis before treatment begins to support individualized planning.

Is MRI safe? Does it use radiation?

MRI does not use ionizing radiation. According to the National Institute of Biomedical Imaging and Bioengineering, MRI uses magnetic fields and radio waves to generate images and is considered a non-invasive imaging modality when appropriate screening guidelines are followed.

Does Neurotherapeutix accept insurance?

Neurotherapeutix is a private-pay practice. We do not submit claims, communicate with insurance companies, or manage reimbursement requests on behalf of patients. However, we provide visit documentation, clinical records, and billing information for patients who choose to pursue reimbursement independently.

How do I find out if I’m a candidate for fMRI-guided TMS therapy?

The first step is a consultation. During the evaluation process, clinicians review your symptoms, medical history, prior treatments, and treatment goals to determine whether fMRI-guided TMS therapy may be appropriate for your situation.

Mental health care is becoming more personalized — and more precise.

While psychotherapy remains a cornerstone of treatment, advances in neuroscience are helping clinicians better understand how and where symptoms originate in the brain.

This is where computational brain mapping and therapy come together. At Neurotherapeutix, we combine psychotherapy with fMRI-guided computational brain mapping to better understand each patient’s unique brain activity and tailor treatment accordingly. This approach does not replace therapy — it enhances it by aligning treatment with how the brain actually functions.

Why psychotherapy alone sometimes falls short

Psychotherapy is highly effective for many individuals, but outcomes can vary. Two people with similar symptoms may respond very differently to the same therapeutic approach.

This is because mental health conditions are not only shaped by life experiences; they are also influenced by underlying brain network activity.

In some cases:

• Brain regions involved in mood or emotional regulation may be underactive
• Neural circuits may be overactive or poorly connected
• Communication between networks may be disrupted

When these patterns are present, it can be more difficult for patients to fully engage with or benefit from therapy alone. This does not mean therapy is ineffective; it means the brain may need additional support to respond more effectively.

What computational brain mapping reveals

Brain mapping uses advanced imaging to analyze how different regions of the brain communicate.

At Neurotherapeutix, this process is guided by fMRI-based computational brain mapping, which evaluates functional connectivity across neural networks.

Rather than focusing on structure alone, this approach reveals:

• How brain regions interact in real time
• Which networks are overactive, underactive, or out of sync
• How these patterns relate to symptoms

Research has shown that combining fMRI with TMS allows clinicians to observe how neural circuits are both measured and modulated, offering deeper insight into how targeted stimulation can influence brain activity.

This level of detail is what enables a more personalized and precise approach to care.

How computational brain mapping enhances psychotherapy

When combined with psychiatric services, computational brain mapping provides a clearer understanding of where and how treatment should be focused.

Aligning stimulation with the circuit therapy targets

Psychotherapy helps individuals reshape thoughts, behaviors, and emotional responses. These processes are supported by specific brain networks.

Using fMRI-guided TMS therapy, clinicians can target the specific circuits involved in these processes. This alignment helps ensure that brain stimulation supports the same pathways being engaged in therapy.

Emerging research suggests that combining TMS with therapeutic interventions may enhance treatment outcomes by influencing the brain’s cognitive and emotional state during care.

In practical terms, this means therapy may become more effective when the underlying brain networks are functioning more optimally.

Identifying the right target for the right patient

No two brains are identical. Even individuals with the same diagnosis may have very different patterns of neural activity.

Computational brain mapping allows clinicians to:

• Identify patient-specific treatment targets
• Avoid relying on generalized anatomical assumptions
• Adjust treatment based on how the brain responds over time

This is a key distinction between standard approaches and precision psychiatry treatment, where care is tailored to the individual rather than the diagnosis alone.

The Neurotherapeutix integrated care model

At Neurotherapeutix, treatment is designed as a coordinated, multi-layered process.

Patients move through a structured care pathway:

• Initial consultation and evaluation
• Functional brain imaging and mapping
• Personalized TMS targeting
• Integration with psychotherapy and psychiatric care
• Ongoing monitoring and adjustment

In addition to TMS therapy, patients may receive support through:

• Psychiatric services
• Therapy coordination and guidance
• Ongoing clinical oversight

This integrated model ensures that each component of care works together, rather than in isolation.

It also reflects Neurotherapeutix’s position as the only clinical practice in the United States offering patented fMRI-guided TMS therapy within a fully integrated mental health care framework.

Who benefits from this integrated approach?

Combining computational brain mapping with psychotherapy may be particularly beneficial for individuals who:

• Have not experienced sufficient improvement with therapy or medication alone
• Are seeking a more personalized approach to mental health care
• Are managing conditions involving disrupted brain connectivity

This includes conditions such as depression, anxiety, post-traumatic stress disorder (PTSD), and other disorders where brain network function plays a central role.

For these individuals, integrating neuroscience-guided mental health care with psychotherapy can provide a more comprehensive and targeted path forward.

Take the next step toward personalized mental health care

Mental health treatment is most effective when it reflects the individual — not just the diagnosis.

By combining computational brain mapping and therapy, Neurotherapeutix offers a more precise and integrated approach to care, designed around how your brain actually functions.

If you’re ready to explore a more personalized path forward, learn more about how it works and request an appointment to see how this approach may support your treatment.

Frequently asked questions

Does computational brain mapping replace psychotherapy at Neurotherapeutix?

No. Computational brain mapping is used to enhance and personalize treatment. Psychotherapy remains an essential part of care, and this approach is designed to support, not replace, it.

How does fMRI-guided TMS therapy complement psychotherapy?

fMRI-guided TMS therapy helps improve how brain networks function, making it easier to engage with and benefit from therapy. By targeting the circuits involved in emotional regulation and cognition, it supports the same processes that therapy aims to strengthen.

Is computational brain mapping safe?

Yes. fMRI-based brain mapping is non-invasive and does not involve radiation. It has a strong safety profile when performed in a clinical setting.

What conditions benefit most from combining computational brain mapping with therapy?

This approach is often used for conditions such as depression, anxiety, PTSD, and other disorders linked to disrupted brain connectivity.

How is Neurotherapeutix different from other TMS therapy clinics?

Neurotherapeutix is the only clinical practice in the United States using patented fMRI-guided computational brain mapping to guide TMS therapy. This approach allows clinicians to identify and target the specific brain networks involved in each patient’s symptoms, rather than relying on generalized anatomical assumptions.

This level of precision is what defines our personalized approach. You can learn more about how personalized TMS vs standard TMS differs from traditional methods and why individualized brain targeting plays a critical role in treatment.

By integrating advanced brain imaging with psychotherapy and psychiatric care, Neurotherapeutix offers a more comprehensive and tailored approach to mental health treatment.

Completing treatment is a meaningful milestone, but for many patients, it naturally leads to the next question: how do I maintain these changes over time?

If you’ve experienced improvement after fMRI-guided TMS therapy, those results reflect more than temporary symptom relief. They represent measurable changes in how your brain networks communicate and regulate function.

The next phase of care focuses on maintaining those gains.

At Neurotherapeutix, treatment is not viewed as a single endpoint but as part of an ongoing process to support brain function, stability, and long-term neuroplasticity.

What happens to the brain after fMRI-guided TMS therapy

fMRI-guided TMS therapy works by influencing how specific brain networks communicate.

During treatment, targeted stimulation helps regulate activity in circuits involved in mood, cognition, and emotional processing.

These changes are driven by neuroplasticity — the brain’s ability to adapt, reorganize, and form new connections.

Research shows that TMS can induce changes at multiple levels of brain function, including synaptic plasticity and network connectivity, with effects measurable through functional imaging.

In practical terms, this means your brain has begun to operate differently. Communication between regions becomes more efficient, emotional responses may feel more regulated, and previously disruptive patterns can begin to shift.

These changes can persist, but like any biological adaptation, they benefit from continued support and reinforcement.

Why personalized network targeting supports longer-lasting results

One of the defining differences of fMRI-guided computational brain mapping and therapy is precision.

Traditional TMS approaches rely on generalized anatomical targeting. In contrast, fMRI-guided TMS therapy is based on how your brain is functioning in real time, allowing clinicians to identify and target the specific networks involved in your symptoms.

This level of personalization plays an important role in long-term outcomes.

When treatment aligns with the underlying neural circuitry, the changes that occur are more directly linked to symptom improvement. As a result, the brain is better positioned to sustain those changes beyond the initial course of care.

Rather than creating temporary adjustments, fMRI-guided treatment supports more meaningful shifts in how brain networks function.

Supporting your brain networks after treatment

Maintaining results is not dependent on a single factor. It involves continuing to support the same neural systems that were strengthened during treatment.

Ongoing engagement with psychiatric services such as therapy and mental health coaching can help reinforce the cognitive and emotional patterns supported by TMS.

As brain networks become more regulated, patients are often better able to apply therapeutic strategies, build resilience, and maintain progress over time.

Sleep also plays a critical role in sustaining neuroplastic changes. During sleep, the brain consolidates new learning and strengthens neural connections. Sleep disruptions can interfere with this process, making consistent, high-quality rest an important part of maintaining results.

Lifestyle factors further contribute to brain health. Physical activity, nutrition, and stress management all influence neuroplasticity, including pathways related to brain-derived neurotrophic factor (BDNF), which supports synaptic growth and adaptation.

At the same time, it is equally important to be aware of factors that can disrupt progress.

Chronic stress, inconsistent routines, and poor sleep can place strain on neural systems and reduce the stability of treatment gains. Maintaining awareness of these influences can help protect the changes achieved during therapy.

Maintenance TMS therapy sessions: when and why

For some individuals, maintaining progress may include periodic maintenance TMS sessions.

These sessions are not a restart of treatment but a continuation of care designed to reinforce the neural networks strengthened during the initial course. They can help stabilize brain activity and support ongoing neuroplastic changes.

Clinical research suggests that maintenance protocols and booster sessions can extend treatment benefits and help sustain improvements over time.

The need for maintenance varies from person to person. Some individuals maintain results without additional intervention, while others benefit from occasional reinforcement based on changes in symptoms, stress levels, or life circumstances.

At Neurotherapeutix, maintenance recommendations are guided by each patient’s brain activity, clinical response, and overall progress.

What to watch for: signs that networks may need attention

An important part of maintaining results is recognizing early signs that your brain networks may need additional support.

This may include gradual changes in mood, increased difficulty with emotional regulation, or shifts in focus and resilience. These changes are often subtle at first and do not indicate that treatment has failed. Instead, they may reflect normal fluctuations in brain activity.

Addressing these changes early allows for more targeted support, whether through therapy, lifestyle adjustments, or maintenance treatment.

Continuing your TMS therapy progress after treatment

The progress you’ve made is meaningful, and it can be sustained.

At Neurotherapeutix, care extends beyond the initial course of treatment. Through ongoing support, personalized guidance, and a focus on long-term brain health, we help patients maintain and build on the changes they’ve achieved.

If you have questions about maintaining your results or are considering next steps, we invite you to reconnect with our team and explore how continued care can support your progress over time.

Frequently asked questions about maintaining results

How long do the effects of fMRI-guided TMS therapy last?

Though individual results vary, many patients experience profound and sustained improvement. Because rsfMRI-guided TMS pinpoints specific brain networks, it promotes lasting structural changes in the brain. This precision yields highly durable therapeutic benefits that significantly outperform standard, generalized treatments.

Do I need maintenance TMS therapy sessions after completing treatment?

Not all patients require maintenance sessions. However, they can be beneficial for reinforcing results, particularly during periods of increased stress or change.

At Neurotherapeutix, we perform a post-treatment computational brain mapping using rsfMRI to compare against your baseline scans. This allows us to objectively measure your progress and plan the best next steps, ensuring that your personalized care is guided by your unique brain imaging at all times.

What lifestyle habits best support neuroplasticity after TMS therapy?

Consistent sleep, regular physical activity, stress management, and continued engagement with therapy or coaching all support neuroplasticity and help maintain brain network changes.

Can therapy help maintain the brain changes induced by fMRI-guided TMS?

Yes. Therapy reinforces the cognitive and emotional patterns supported by TMS, making it an important part of sustaining long-term results.

How will I know if my brain networks need a booster treatment?

Gradual shifts in mood, focus, or emotional regulation may indicate that additional support could be helpful. A clinical evaluation can help determine the most appropriate next step.

We highly recommend follow-up computational brain mapping to objectively monitor your progress, maintain your results, and help prevent relapse.

Starting treatment for a mental health or neurological condition can feel overwhelming, especially when advanced imaging and personalized brain analysis are involved. Many patients want to understand what happens between the first consultation, the scan, and the start of treatment.

At Neurotherapeutix, the brain mapping approach is built around fMRI-based computational analysis, an advanced method that evaluates how different regions of the brain communicate.

Rather than relying on generalized anatomical assumptions, clinicians use functional connectivity data to identify the specific neural circuits involved in each patient’s symptoms.

From your initial consultation through your first TMS session, every step is designed to create a more personalized treatment strategy based on how your brain functions in real time.

What is the computational brain mapping process?

The computational brain mapping process combines functional imaging, clinical evaluation, and advanced analysis to better understand how different regions of the brain communicate.

At Neurotherapeutix, this process centers on resting-state functional MRI (rsfMRI), which measures functional connectivity across neural networks while the brain is at rest.

Unlike structural imaging alone, computational analysis evaluates how the brain functions in real time. This helps clinicians identify patterns of overactivity, underactivity, or disrupted communication that may contribute to symptoms involving mood, cognition, emotional regulation, and neurological function.

Why computational brain mapping comes first

Many traditional TMS approaches rely on generalized anatomical landmarks when selecting stimulation targets. Neurotherapeutix takes a more personalized approach.

By beginning with fMRI-based computational brain mapping, clinicians can identify the specific neural circuits associated with each patient’s symptoms before treatment starts.

Research has shown that connectivity-based targeting may improve treatment response by aligning stimulation with the brain networks most relevant to the condition being treated.

This precision-driven approach is central to Neurotherapeutix’s care model. It reflects the clinic’s position as the only clinical practice in the United States using patented fMRI-guided computational brain mapping to guide TMS therapy.

Step 1 — your initial consultation

The process begins with a detailed consultation and clinical evaluation.

During this stage, clinicians review your symptoms, treatment history, goals, and overall health to determine whether fMRI-guided TMS therapy may be appropriate for you.

This conversation helps establish the clinical context needed to interpret imaging results and personalize treatment planning.

Patients also learn more about how fMRI-guided TMS therapy works and what to expect throughout treatment.

This consultation is designed to go beyond a diagnosis alone. Two people with similar symptoms may have very different patterns of brain connectivity, which is why individualized evaluation is so important.

Step 2 — the rsfMRI brain scan

The next step is the resting-state fMRI (rsfMRI) scan.

During the scan, you will lie comfortably in an MRI machine while the system measures how different regions of your brain communicate at rest. Unlike task-based scans, rsfMRI does not require you to complete exercises or respond to prompts during imaging.

Instead of relying on limited task-based imaging, our scan captures functional connectivity patterns across neural networks in their natural resting state. This superior approach allows for a comprehensive, whole-brain analysis to map how networks interact. Research shows that analyzing this complete brain topology is actually the best predictor of behavior and task performance, giving us the most accurate map of your symptoms.

What the scanner is looking for

The scan evaluates how different brain regions interact and coordinate.

Clinicians analyze:

• Which networks may be overactive or underactive
• How emotional regulation circuits communicate
• Patterns associated with mood, cognition, and stress response
• Areas where connectivity may be disrupted

This information becomes the foundation for computational analysis and personalized treatment planning.

At Neurotherapeutix, our cutting-edge computational brain mapping technology identifies brain abnormalities with millimeter-level precision. This allows us to move beyond standard TMS approaches that rely on generalized anatomical locations. Instead, we can pinpoint the exact abnormal regions unique to your brain, guiding our targeting with significantly greater precision to create a truly personalized treatment plan.

Patients interested in learning more about imaging differences can also explore how rsfMRI compares to SPECT imaging.

Is the scan safe?

Yes. MRI and rsfMRI are non-invasive imaging methods that do not involve ionizing radiation.

According to the National Institute of Biomedical Imaging and Bioengineering, MRI uses magnetic fields and radio waves to generate detailed images without exposing patients to radiation.

The scanning process is completely painless and generally very well-tolerated by our patients. While the imaging machine does produce some loud sounds and can feel a bit cozy, our team will ensure you are comfortable and supported throughout the entire experience.

Step 3 — computational analysis and treatment planning

After the scan is completed, the imaging data undergoes computational analysis.

During this stage, we evaluate functional connectivity across your neural networks to identify specific patterns of disrupted activity. By providing a complete topology of your whole-brain activity, our clinicians can support specific clinical diagnoses and pinpoint the exact circuits associated with your symptoms. With this deep understanding, we then customize a precise treatment plan designed specifically for you, directly addressing the unique abnormalities causing your condition.

Rather than applying a standardized protocol, treatment planning is guided by how your brain is functioning individually.

How your brain connectivity map guides targeting

Your connectivity analysis acts as a blueprint for treatment.

Using this information, clinicians can:

• Identify personalized stimulation targets
• Align treatment with symptom-related circuits
• Adjust targeting based on your specific neural activity patterns

This precision-driven process is one of the key differences between fMRI-guided treatment and traditional TMS approaches.

Because targeting is based on your individual brain connectivity patterns rather than generalized anatomy, the goal is to support more meaningful and durable changes in neural function.

Step 4 — your first TMS session

Once the computational brain mapping analysis is complete and the specific targets for your personalized care have been identified, your treatment begins.

During your fMRI-guided TMS therapy session, we use advanced neuronavigational technology to guide your treatment in real time. You will actually be able to see your own brain on the screen as the software guides our clinicians, ensuring the magnetic coil is positioned directly on top of the precise, personalized targets we previously uploaded into the system.

The treatment uses magnetic pulses to stimulate the neural circuits involved in mood regulation, cognition, or emotional processing.

TMS is non-invasive and does not require anesthesia or sedation. Most sessions are completed in under an hour, and patients typically return to their normal daily activities afterward.

What to expect over a full treatment timeline

TMS therapy is a process that unfolds over time.

While some patients notice changes early, meaningful improvement often develops gradually as the brain adapts, strengthening correct neural pathways and creating healthy new patterns of connectivity. This process is tied to neuroplasticity — the brain’s ability to reorganize and form new neural pathways.

At Neurotherapeutix, treatment plans are designed not only to reduce symptoms but to support lasting changes in how brain networks function.

Throughout treatment, clinicians monitor progress and make adjustments as needed based on response and brain function.

Ready to see your brain?

The computational brain mapping process is the only way to truly personalize your treatment, ensuring your care is precise, exact, and informed from the very beginning.

By combining advanced imaging with computational analysis and individualized targeting, Neurotherapeutix helps patients better understand how their brain functions and how treatment can be tailored to their needs.

If you are ready to learn more about how fMRI-guided TMS therapy works or begin the process, you can request a consultation to speak with the team.

Frequently asked questions

Does everyone at Neurotherapeutix start with a brain scan?

Yes, all patients begin with computational analysis because it provides the functional data needed to personalize treatment targeting. Imaging is a central part of Neurotherapeutix’s precision-guided approach.

How long does the computational brain mapping process take from scan to first session?

The timeline from your initial consultation to your first treatment is highly efficient. After your consultation, your fMRI scan is usually scheduled immediately, typically taking place within 2 to 3 days. Once the scan is complete, our comprehensive computational brain mapping analysis takes exactly one week. As soon as those results are finalized and your specific treatment targets are identified, your fMRI-guided TMS sessions can begin.

Will I see my brain map?

Yes. Clinicians review imaging findings with patients as part of the treatment planning process and explain how the results relate to symptoms and targeting.

What if I’ve already had standard TMS — does the process change?

Patients who have previously undergone standard TMS with limited success, no success, or even a worsening of symptoms can still benefit immensely from our fMRI-guided approach. We have successfully treated many patients in this exact situation. Because our advanced computational brain mapping evaluates your unique, individual brain connectivity rather than relying on generalized anatomical assumptions, we are able to pinpoint the exact root of the problem and fully personalize a treatment that finally works for you.

Does insurance cover the rsfMRI scan?

Neurotherapeutix is a private-pay practice. We do not submit claims, contact insurance companies, or handle reimbursement matters on behalf of patients. Instead, we provide visit summaries, superbills, medical records, and billing documentation so patients can independently pursue out-of-network reimbursement if they choose to do so.

When it comes to brain stimulation, small differences in location can have a significant impact.

The brain is not organized into broad, isolated regions working independently. It functions through highly interconnected neural networks, many of which are separated by only millimeters but serve very different roles in mood regulation, cognition, emotional processing, and behavior.

This is why precision matters.

At Neurotherapeutix, computational brain mapping is used to identify the specific neural circuits underlying each patient’s symptoms before treatment begins.

Rather than relying on generalized anatomical assumptions, clinicians use fMRI-based connectivity analysis and neuronavigation to guide stimulation with millimeter-level accuracy.

This precision-driven approach is one of the defining differences between standard TMS protocols and personalized fMRI-guided treatment.

The problem with “close enough” in brain stimulation

In many areas of medicine, “close enough” may still produce acceptable results. In brain stimulation, however, even slight differences in targeting can affect which neural networks are being stimulated.

Two treatment targets may appear anatomically similar while functioning very differently within the brain’s connectivity system. Stimulating one network may support emotional regulation and symptom improvement, while stimulating a nearby but different circuit may produce less effective or inconsistent results.

This is especially important in mental health conditions, where symptoms are often linked to disruptions in network communication rather than visible structural abnormalities.

The challenge is not simply reaching the brain — it is reaching the right network with enough precision and consistency to influence how that network functions over time.

What standard TMS gets right — and what it can’t account for

Standard transcranial magnetic stimulation (TMS) has helped expand access to non-invasive brain stimulation and remains an important treatment option for many patients.

According to the National Institute of Mental Health, TMS is an established brain stimulation therapy used for certain mental health conditions.

However, traditional protocols often rely on generalized anatomical targeting methods based on average brain positioning rather than individual connectivity patterns.

This approach assumes that the same anatomical location will produce similar outcomes across patients, even though no two brains function exactly alike.

At Neurotherapeutix, the goal is to move beyond generalized positioning with fMRI-guided TMS therapy rather than standard TMS and to evaluate how each patient’s neural networks communicate individually.

This distinction is critical because symptoms such as depression, anxiety, post-traumatic stress disorder (PTSD), and cognitive dysfunction are often tied to network-level disruptions rather than a single isolated brain region.

What precision brain mapping actually measures

Precision brain mapping focuses on functional connectivity — how different regions of the brain communicate and coordinate with one another.

At Neurotherapeutix, this process is guided through rsfMRI, or resting-state functional MRI, which evaluates brain network activity while the patient is at rest.

Unlike structural imaging alone, rsfMRI helps clinicians understand how neural systems interact in real time.

From blood oxygen signals to a connectivity map

rsfMRI measures subtle fluctuations in blood oxygen levels, known as BOLD signals, which reflect neural activity across different brain regions.

By analyzing these signals computationally, clinicians can identify:

• Networks that may be overactive or underactive
• Patterns of disrupted communication
• Connectivity associated with mood, cognition, or emotional regulation

Research has shown that connectivity-based targeting may improve antidepressant response in TMS by aligning stimulation with symptom-related neural networks.

This information becomes the foundation for personalized targeting.

Patients interested in imaging comparisons can also explore rsfMRI vs. SPECT imaging to better understand how different technologies evaluate brain function.

How millimeter resolution translates to a treatment target

MRI technology offers extremely high spatial resolution, allowing clinicians to evaluate brain structures and connectivity patterns with remarkable detail.

In practical terms, this means clinicians can identify highly specific treatment targets rather than relying on generalized coordinates.

Millimeter-level accuracy matters because nearby brain regions may belong to entirely different neural networks. Precision targeting helps ensure stimulation is directed toward the circuits most closely associated with the patient’s symptoms.

How Neurotherapeutix achieves millimeter accuracy

At Neurotherapeutix, precision extends beyond the initial scan and continues throughout treatment.

Once imaging and computational analysis identify the appropriate target, clinicians use fMRI-guided TMS therapy protocols combined with neuronavigation technology to maintain highly accurate positioning during every session.

This approach helps ensure that treatment remains aligned with the intended neural circuits across the full course of therapy.

The role of neuronavigation in every TMS session

Neuronavigation acts as a real-time guidance system during treatment.

Using imaging data and spatial tracking, clinicians can precisely position the TMS coil relative to the patient’s individualized treatment target. This allows for consistent targeting session after session.

Without neuronavigation, even small shifts in positioning could alter which brain networks receive stimulation.

At Neurotherapeutix, maintaining precision across sessions is considered essential because consistent targeting supports more reliable network modulation over time.

Why consistent targeting across sessions matters

TMS therapy is not a one-time intervention. It works through repeated stimulation over multiple sessions as the brain gradually adapts and strengthens new connectivity patterns.

This process is tied to neuroplasticity — the brain’s ability to reorganize and form new neural pathways.

If targeting varies significantly between sessions, stimulation may not consistently engage the same neural circuits. Precision and consistency help reinforce the intended network changes throughout treatment.

This is one reason why individualized targeting and neuronavigation can play such an important role in treatment planning and long-term outcomes.

You can learn more about how it works now.

What this means for your treatment outcomes

For patients, precision-guided care means treatment is designed around how their brains function —not around generalized averages.

This may help:

• Improve targeting accuracy
• Better align stimulation with symptom-related networks
• Support more consistent modulation across sessions
• Create more meaningful and durable changes in connectivity

At Neurotherapeutix, precision is viewed as a clinical necessity rather than an added feature.

The goal is not simply to stimulate the brain, but to stimulate the right networks with the level of accuracy needed to support individualized treatment outcomes.

Precision starts here

At Neurotherapeutix, advanced imaging, computational analysis, and neuronavigation are integrated to create a more precise and personalized approach to brain stimulation.

By combining fMRI-guided targeting with millimeter-level accuracy, clinicians can tailor treatment to the neural circuits most closely associated with each patient’s symptoms.

If you are interested in learning more about precision-guided care, you can request a consultation to speak with the team.

Frequently asked questions

How precise is Neurotherapeutix’s brain mapping compared to standard TMS?

Standard TMS often relies on generalized anatomical landmarks, while Neurotherapeutix uses fMRI-guided computational brain mapping and neuronavigation to identify and target individualized neural circuits with millimeter-level accuracy.

What is neuronavigation, and how is it used during TMS sessions?

Neuronavigation is an advanced guidance system that uses imaging data and spatial tracking to allow clinicians to visualize the brain while the patient is comfortably seated in the treatment chair. This technology enables us to precisely position the coil over the exact brain regions identified during computational brain mapping. By continuously guiding placement and monitoring movement in real time, the system ensures highly accurate, consistent targeting across every session.

Does millimeter precision actually improve treatment outcomes?

Yes. Research suggests that connectivity-based targeting significantly improves treatment response by doing more than just providing millimeter precision. It allows us to detect the exact, specific regions of the brain that are malfunctioning for each patient. By aligning stimulation directly with these symptom-related neural networks, this precision targeting ensures a highly personalized approach and maintains consistent precision throughout the entire treatment course.

Does insurance cover fMRI-guided computational brain mapping?

Neurotherapeutix is a private-pay practice. We do not submit claims, contact insurance companies, or handle reimbursement matters on behalf of patients. Instead, we provide visit summaries, superbills, medical records, and billing documentation so patients can independently pursue out-of-network reimbursement if they choose.

Who is a good candidate for computational brain mapping?

Individuals seeking a highly personalized approach to TMS therapy are excellent candidates, particularly those with treatment-resistant conditions or prior experience with standard TMS.

Furthermore, patients with any symptoms are good candidates, as our computational brain mapping technology provides a thorough analysis of whole-brain activity and connectivity. This comprehensive evaluation supports specific diagnoses, uncovers the neurological root of your symptoms, and creates a personalized care plan by identifying the exact brain regions to target for treatment.

Computational brain mapping is an ideal next step if standard treatments like medication or therapy haven’t provided the relief you need. It offers a highly personalized, brain-based approach designed to target the unique root of your symptoms.

If you’ve been exploring options for depression, anxiety, or other neurological or psychiatric conditions, it may be time to look deeper at how your brain is functioning.

At Neurotherapeutix, our fMRI-guided TMS is built to do exactly that—utilizing advanced imaging to drive precise, highly targeted, and individualized treatment decisions.

In this guide, we’ll explain what computational brain mapping involves, who may be a candidate, and what to expect if you’re considering this approach.

What is brain mapping?

At Neurotherapeutix, we use fMRI-based computational brain mapping to assess brain function and connectivity patterns.

Functional MRI (fMRI) measures changes in blood flow to identify which areas of the brain are active and how different regions communicate. This allows clinicians to evaluate neural networks involved in mood regulation, cognition, and behavior.

This information is used to guide fMRI-guided TMS therapy by identifying specific neural circuits that may benefit from targeted stimulation.

Traditional TMS relies on generalized anatomical landmarks, placing the magnetic coil based on standard protocols that treat every brain as if it were the same.

In stark contrast, fMRI-guided TMS uses advanced imaging to map your individual brain activity. Because every brain functions differently, this allows us to move away from rigid, standardized protocols and instead tailor your stimulation targets to your unique neural pathways for maximum precision.

Who is a candidate for computational brain mapping?

Computational brain mapping may be considered for individuals seeking a more personalized approach to understanding and treating neurological or psychiatric symptoms.

The expert team at Neurotherapeutix works with patients to target and treat a range of neurological conditions effectively.

You may be a candidate if you:

• Continue to experience symptoms despite therapy or medication
• Are managing conditions such as depression, anxiety, PTSD, OCD, or ADHD
• Have experienced a traumatic brain injury (TBI) or cognitive changes
• Have complex or co-occurring conditions
• Are interested in a data-driven, individualized treatment approach

Computational brain mapping may be appropriate for individuals who have not experienced sustained improvement with standard care and are seeking a more targeted evaluation of brain function.

According to the National Institute of Mental Health, many individuals with depression do not respond fully to initial standard treatments, which highlights the need for more personalized approaches that can be found through fMRI-guided TMS therapy.

When to consider computational brain mapping

fMRI-guided computational brain mapping is often considered when standard treatment approaches have not provided consistent results.

However, it may also be appropriate for individuals who want a clearer understanding of their condition before continuing treatment.

You may consider computational brain mapping if:

• Symptoms persist despite ongoing care
• You want to better understand the underlying drivers of your symptoms
• Your condition involves multiple or overlapping diagnoses
• You prefer a treatment approach guided by objective data

This approach is not limited to a specific stage of care. It can inform next steps and support more individualized treatment planning.

What to expect

Understanding the process can help you feel more comfortable when considering this option.

Initial consultation

Your care team will review your medical history, symptoms, and treatment goals to determine whether fMRI-guided treatment is appropriate.

The fMRI scan

Your brain scan is non-invasive and typically takes about 60 minutes. During this time, we use high-resolution imaging to measure your brain activity and map your unique neural connectivity patterns.

If you have concerns about comfort or claustrophobia, these can be discussed during your consultation so appropriate support can be provided.

Personalized treatment plan

This imaging data is processed through our patented computational algorithms. Using this advanced fMRI-based brain mapping, we can definitively identify the unique neural networks driving your symptoms.

From there, we develop a highly personalized treatment plan, allowing us to actively adjust and refine your stimulation targets as your brain connectivity evolves and improves over time.

Taking the next step

If you are considering whether fMRI-guided computational brain mapping may be appropriate for you, the next step is a clinical consultation.

This appointment allows your care team to evaluate your symptoms, review your treatment history, and determine whether this approach aligns with your needs.

You may want to bring:

• Relevant medical records
• A list of current medications
• Questions about your symptoms or treatment goals

You can also learn more about the physicians guiding your care by exploring our team of specialists.

A more personalized path forward is possible with Neurotherapeutix in NYC

For many people, ongoing symptoms are not a sign that they aren’t trying hard enough—they are simply a sign that they need a more personalized, individualized approach to care.

fMRI-guided TMS therapy provides a way to better understand brain function and support treatment decisions using objective data.

By focusing on neural connectivity patterns, this approach allows care to be tailored to each patient’s specific needs.

If you are exploring next steps in your treatment journey, a consultation can help determine whether this approach may be appropriate for you.

Please request an appointment to learn more and discuss your options with our team.

Choosing a treatment for depression, anxiety, or other neurological or psychiatric conditions is deeply personal. If you’ve been exploring options, you may already know that not all TMS approaches are the same.

fMRI-guided TMS therapy uses advanced imaging to help personalize treatment based on your brain’s activity, rather than relying on standardized protocols.

This data-driven approach, pioneered by our Neurotherapeutix team, is designed to support more targeted care and a clearer understanding of what may be contributing to your symptoms.

Before starting treatment, it’s important to feel informed and confident in your decision.

This guide outlines key questions (and answers!) to help you better understand your options, evaluate provider expertise, and know what to expect from care.

Key questions to ask before starting fMRI-guided TMS therapy

Before your consultation, it can be helpful to come prepared with a clear set of questions. This allows you to better understand your options, evaluate your provider’s approach, and feel more confident in your next steps.

Here are some key questions to ask:

• Am I a good candidate for this treatment?
• How will computational brain mapping guide my care?
• What makes this approach different from standard TMS?
• What results should I realistically expect?
• Who will oversee my treatment and imaging?
• What are the costs, time commitment, and next steps?

Understanding your candidacy and treatment goals

Am I a good candidate for fMRI-guided TMS therapy?

Candidacy is based on your symptoms, treatment history, and overall clinical profile. Broadly speaking, you may be a strong candidate for this treatment if your condition presents a specific biomarker signature in the brain, which our patented, cutting-edge imaging technology is designed to detect and target.

Many patients consider fMRI-guided TMS therapy after not finding consistent relief with standard treatments.

Our providers will evaluate how your diagnosis, prior treatments, and goals align with this type of care.

What specific outcomes can I expect for my condition?

fMRI-guided TMS therapy treats a wide range of neurological, neurodevelopmental, and psychiatric conditions.

Outcomes can vary depending on your condition and individual brain connectivity patterns. It’s important to understand both the potential benefits and the expected timeline for improvement.

Your provider can help you understand:

• What improvements are commonly seen for your condition
• How long it may take to notice changes
• How progress is monitored over time

What could exclude me from treatment?

Some individuals may not be appropriate candidates for TMS therapy due to safety concerns.

During your consultation, your care team will review your medical history, including any implanted devices or conditions that may affect treatment planning.

If this approach is not recommended, your provider can also discuss alternative options that may better align with your needs.

Questions about the fMRI-guided approach

How does computational brain mapping work, and what will it show?

Computational brain mapping measures changes in blood flow to evaluate brain activity and connectivity.

This advanced imaging provides our clinicians with a precise functional map of your brain, allowing us to isolate the exact neural communication patterns driving your symptoms.

The first step at Neurotherapeutix is capturing your brain’s activity in its resting state to establish a highly accurate baseline. With this foundational data, our clinical team can precisely identify the specific, misfiring neural circuits at the root of your symptoms.

Because fMRI provides exceptional, high-resolution imaging, we can pinpoint these specific brain regions with millimeter precision. This extraordinary level of detail allows us to design a highly targeted treatment plan, moving far beyond the limitations of standard therapies that rely on generalized anatomical landmarks.

How will my fMRI results guide my treatment plan?

This advanced imaging allows us to isolate the exact neural pathways responsible for your symptoms. Instead of utilizing broad, generalized stimulation, we engineer a precise treatment plan that delivers targeted support exactly where your brain needs it.

This allows your provider to design a treatment plan tailored to your brain’s activity and connectivity patterns. As treatment progresses, your care team can monitor changes and make adjustments when appropriate to support more individualized care.

Will I have follow-up imaging to track progress?

Yes. Follow-up imaging is a key part of our approach. It provides objective data that allows us to see exactly how your brain’s connectivity is improving and responding to treatment over time.

One advantage of fMRI-guided TMS therapy is the ability to track changes in brain connectivity over time, sometimes before changes in symptoms are fully noticeable. This can help guide adjustments to your treatment plan when needed.

What makes fMRI-guided TMS different from standard TMS?

Traditional TMS relies on generalized anatomical landmarks, placing the treatment coil based on standard protocols that assume every patient’s brain is mapped the same way.

In contrast, our cutting-edge, patented fMRI-guided TMS technology relies on your actual imaging data to identify and target the specific neural circuits causing your symptoms. Rather than guessing with uniform treatment locations, this advanced approach ensures your care is completely individualized to reflect how your unique brain functions.

This precise targeting forms the foundation of a truly personalized treatment plan—one that allows us to continuously monitor your progress and make data-driven adjustments based on how your brain responds to care.

Provider expertise and clinical experience

What is your team’s training and experience with fMRI-guided TMS therapy?

fMRI-guided TMS is a highly specialized and evolving area of care, and provider expertise plays a central role in planning and delivering treatment.

Neurotherapeutix was founded by a clinical neuroscientist and an MRI physicist, reflecting a deep integration of neuroscience and imaging expertise.

As pioneers in the clinical application of this patented, fMRI-guided approach, our expert team brings a research-driven perspective to personalized brain health.

When evaluating a provider, it can be helpful to understand:

• How long they have been working with fMRI-guided TMS
• Their training in both neuroimaging and neuromodulation
• The range of conditions they have experience treating

Who will perform my treatments and interpret my brain scans?

Because this approach relies on advanced imaging, it’s important to understand how different specialists are involved in your care.

At Neurotherapeutix, treatment is guided by a collaborative team that includes physicians, imaging specialists, and TMS clinicians.

Your brain imaging is interpreted through our patented fMRI-based computational analysis, an advanced technology that enables the precise identification of the exact neural networks involved in your symptoms.

Understanding how your care team works together, from imaging to treatment delivery, can help you feel more confident in the process and the level of precision guiding your care.

Can you share outcomes from patients with similar conditions?

While outcomes vary from person to person, experienced providers can offer general insight into how patients with similar conditions may respond to treatment.

This may include:

• Common patterns of improvement observed over time
• How progress is measured beyond symptom changes
• How treatment plans are adjusted based on individual response

Because fMRI-guided TMS therapy is personalized, your provider can help you understand how your case may compare to others while emphasizing that treatment is tailored to your unique brain activity and connectivity patterns.

Treatment logistics and what to expect

How many sessions will I need, and how long is each appointment?

fMRI-guided TMS therapy is delivered over a series of outpatient sessions, allowing stimulation to build gradually and support longer-term changes in brain connectivity.

The exact number of sessions, frequency, and duration of each appointment are personalized based on your clinical needs and how your brain responds to treatment.

Your treatment schedule is as customized as your care. While many plans involve multiple sessions over several weeks with flexible scheduling, we also offer condensed options—such as multiple sessions per day over consecutive days or grouped sessions on specific days. Your exact schedule will be tailored to your imaging findings, clinical needs, and personal availability.

Your provider will outline a plan tailored to you and may adapt it over time based on your progress.

What will TMS feel like, and what are the common side effects?

TMS is a non-invasive treatment that does not require anesthesia or downtime.

During sessions, a magnetic coil is placed on the scalp over targeted brain regions identified through fMRI analysis.

You may feel a light tapping or pulsing sensation during treatment. Most patients remain awake and alert and can return to daily activities immediately afterward.

Common side effects are typically mild and temporary and may include scalp discomfort or a mild headache.

According to the National Library of Medicine, TMS is generally well tolerated when administered in accordance with appropriate clinical guidelines.

Can I continue my current medications during treatment?

Treatment plans are individualized, and medication use is reviewed during your clinical evaluation.

In many cases, patients can continue their current medications. Your care team will assess how your medications align with TMS therapy and make recommendations to support both safety and effectiveness throughout your treatment course.

What happens after my treatment course is complete?

After your initial course of treatment, your care team will evaluate your progress and discuss next steps based on your response.

Some patients may also benefit from a maintenance phase, where sessions are strategically spaced over time to support long-term relief and continued improvements in brain connectivity.

All follow-up care is customized to your needs, using ongoing clinical evaluations and brain imaging to guide your long-term treatment plan.

Insurance, costs, and practical considerations

Does my insurance cover fMRI-guided TMS?

Insurance coverage for fMRI-guided TMS therapy can vary depending on your insurance plan and provider.

Neurotherapeutix is a premier private clinic and operates on a self‑pay basis rather than participating in insurance networks. While we do not communicate with insurance companies directly, our team can support you in exploring out‑of‑network reimbursement by providing detailed visit information, including superbills and relevant clinical records, for you to submit to your insurer.

It’s helpful to understand:

• Whether your plan offers out-of-network benefits
• What documentation is needed for reimbursement
• What portion of care may be eligible for coverage
• What diagnoses are covered

What is the total investment, and are payment plans available?

Understanding the full scope of cost is an important part of making an informed decision.

At Neurotherapeutix, care includes both advanced imaging and personalized treatment:

• fMRI-based computational brain mapping: $5,000 total
  • $1,000 deposit required to schedule
  • Remaining balance due before imaging review
• fMRI-guided TMS therapy sessions: $600 per session

Treatment plans are individualized, so the total number of sessions and overall investment will depend on your specific needs and response to care.

While payment plans are not currently offered, patients can pay for TMS sessions individually as treatment progresses. The care team can also help you understand your options and plan accordingly.

How will treatment fit into my daily schedule?

TMS is typically performed in an outpatient setting, allowing you to return to daily activities after each session.

Your provider can help you understand how treatment fits into your schedule and what level of time commitment is required.

Taking the next step with confidence

An informed patient is an empowered patient.

Asking the right questions can help you better understand your treatment options, evaluate provider expertise, and set realistic expectations for care.

At Neurotherapeutix, our expert team will welcome your questions and take the time to ensure you feel comfortable moving forward.

If you’re considering this approach, the next step is a consultation to discuss your specific needs, review your history, and explore whether fMRI-guided TMS therapy may be appropriate for you.

When you’re ready, you can request an appointment to get answers to your questions and take the next step toward more personalized care.

Anxiety in young adults is becoming a more common part of public conversation, and not just among clinicians. When public figures openly discuss panic attacks and burnout, it helps normalize experiences that many people struggle to explain.

Singer Shawn Mendes has spoken candidly about the emotional toll of constant performance pressure and why stepping back from touring was necessary to prioritize his mental health. His experience reflects a larger trend: many high-functioning young adults are navigating chronic stress, anxiety, and periods of emotional exhaustion while trying to maintain demanding personal or professional expectations.

Understanding why this happens requires looking not only at life circumstances, but also at how anxiety affects the brain and nervous system.

Why anxiety in young adults is on the rise

Young adulthood often involves significant transitions, including academic pressure, career decisions, financial stress, social comparison, and increased digital exposure. Over time, sustained stress can influence how the brain regulates emotional responses.

Many individuals experiencing anxiety still appear high functioning externally. They may continue working, studying, or performing at high levels while feeling exhausted or overwhelmed internally.

This disconnect between appearance and internal experience is one reason anxiety and burnout can build gradually before symptoms become obvious.

Shawn Mendes and panic attacks: A public case study

In interviews about his decision to pause touring, Shawn Mendes described feeling emotionally overwhelmed and disconnected from his sense of balance in life. He explained that constant performance expectations and public scrutiny contributed to growing mental and emotional strain.

While every person’s experience is unique, his story highlights common contributors to anxiety in young adults:

• Ongoing performance pressure
• Limited time for recovery or rest
• High visibility and external evaluation
• Difficulty separating identity from achievement

Public conversations like this help reduce stigma by showing that anxiety and panic symptoms can affect anyone, regardless of success or visibility.

What causes panic attacks in young adults?

Panic attacks are intense episodes of fear or discomfort that can appear suddenly, sometimes without an obvious trigger.

From a neuroscience perspective, panic symptoms often involve heightened activation of brain regions responsible for threat detection and stress response, particularly the amygdala and connected neural networks.

Contributing factors may include:

• Chronic stress exposure
• Sleep disruption
• Burnout or emotional overload
• High baseline anxiety
• Nervous system sensitivity

When these systems remain activated for extended periods, the brain may begin to respond to everyday situations as if they were threats.

Symptoms of panic attacks you should understand

Panic attacks can feel alarming, especially when symptoms mimic physical medical conditions.

Common symptoms include:

• Rapid heartbeat
• Shortness of breath
• Dizziness or lightheadedness
• Chest tightness
• Sweating or shaking
• Feeling detached or unreal
• Sudden intense fear

Symptoms typically peak within minutes, but the emotional aftereffects can linger longer.

The difference between anxiety and panic attacks

Anxiety and panic attacks are related but not identical.

Anxiety usually builds gradually and involves persistent worry or tension.

Panic attacks tend to occur suddenly and are characterized by intense physical symptoms.

Many individuals experience both, especially when chronic stress increases overall nervous system sensitivity.

How anxiety affects the brain and nervous system

Anxiety involves communication among several brain networks that regulate emotion, detect threats, and support cognitive control.

When stress becomes chronic, these circuits may become less balanced:

• The amygdala may become more reactive
• Stress hormones may remain elevated
• Communication between emotional and regulatory regions can weaken

This imbalance can make it harder to feel calm, even when no immediate danger exists.

Cortisol, burnout, and mental exhaustion

Cortisol is a hormone released during stress. In short bursts, it helps the body respond to challenges. But prolonged cortisol exposure may contribute to mental exhaustion, poor sleep, and emotional burnout.

Over time, chronic stress can lead to symptoms such as:

• Constant fatigue
• Difficulty concentrating
• Emotional numbness or irritability
• Feeling overwhelmed by simple tasks

Burnout and anxiety frequently overlap, especially in young adults managing high expectations without adequate recovery.

Neurobiology of anxiety and neuroplasticity

The good news is that the brain retains the ability to adapt. This process, called neuroplasticity, allows neural pathways to change over time in response to experiences and treatment.

Modern anxiety care increasingly focuses on supporting healthier communication between brain networks rather than only addressing symptoms at the surface level.

Standard anxiety treatment options for young adults

Standard anxiety treatment typically includes:

• Psychotherapy, such as cognitive behavioral therapy (CBT)
• Medication when clinically appropriate
• Stress management and lifestyle adjustments
• Mindfulness or biofeedback approaches

These strategies help many individuals. However, some continue to experience persistent symptoms despite appropriate care.

fMRI-guided TMS therapy for anxiety and panic disorders

For individuals seeking a non-medication, brain-based approach, neuromodulation may be considered.

Traditional TMS uses standard coil placement based on general anatomical landmarks. At Neurotherapeutix, fMRI-guided TMS therapy uses computational brain mapping to identify personalized neural connectivity patterns associated with symptoms.

This allows clinicians to:

• Personalize stimulation targets using imaging data
• Identify misfiring neural networks with millimeter-level precision
• Support healthier communication between brain regions involved in anxiety regulation

Because every brain is unique, treatment is designed around individual neural patterns rather than a standardized protocol.

When to seek professional help for anxiety

You may benefit from a professional evaluation if:

• Anxiety interferes with daily functioning
• Panic symptoms occur repeatedly
• Sleep or concentration are consistently affected
• Burnout or emotional exhaustion continues despite rest
• Symptoms persist or worsen over time

Early support can help prevent symptoms from becoming more entrenched.

Anxiety treatment in NYC at Neurotherapeutix

At Neurotherapeutix, our team provides personalized anxiety care using fMRI-guided TMS therapy in Manhattan.

Our physicians use functional MRI-based computational brain mapping to guide treatment decisions and expert services based on your unique brain connectivity patterns, helping support brain function and strengthen neural connections over time.

If you are exploring advanced anxiety treatment options in New York City, we invite you to request an appointment or contact our team directly to learn more.

FAQs about anxiety, panic attacks, and burnout

If you’ve been exploring treatment options for depression, anxiety, or other neurological or psychiatric conditions, you may be wondering whether transcranial magnetic stimulation (TMS) therapy is right for you.

TMS has become an increasingly recognized option for individuals seeking non-invasive, brain-based care, especially when symptoms persist despite traditional approaches. But candidacy is not based on a single factor. It involves understanding your history, symptoms, and how your brain networks may be functioning.

In this blog, we explain how TMS therapy works, who may qualify, and what to expect if you are considering treatment at Neurotherapeutix in New York City.

What is transcranial magnetic stimulation therapy?

Transcranial magnetic stimulation therapy is a non-invasive treatment that uses magnetic pulses to stimulate specific brain regions involved in mood regulation, emotional processing, and cognitive function.

How TMS therapy works

During treatment, a magnetic coil is placed near your scalp to deliver targeted pulses to brain regions associated with symptoms. These pulses are designed to support healthier communication between neural networks and promote neuroplasticity, which is the brain’s ability to adapt and reorganize.

TMS sessions are performed in an outpatient setting, and patients remain awake and alert throughout treatment.

Standard TMS vs. fMRI-guided TMS therapy

Traditional TMS uses standard coil placement based on general anatomical landmarks and follows protocol-based treatment approaches for most patients.

At Neurotherapeutix, fMRI-guided TMS therapy uses computational brain mapping to personalize stimulation targets based on your unique brain connectivity patterns. This allows clinicians to identify specific neural circuits involved in symptoms and tailor treatment with millimeter-level precision.

Because every brain is different, this approach is designed to reflect your individual neural pathways rather than rely on a one-size-fits-all protocol.

FDA-approved TMS therapy for mental health

According to the Cleveland Clinic, TMS therapy has received FDA clearance for certain mental health conditions, including depression and obsessive-compulsive disorder.

Clinicians may also explore its use for additional conditions based on individual needs, clinical judgment, and evolving neuroscience research.

Am I a candidate for fMRI-guided TMS therapy? Key signs to look for

You may be a strong candidate for fMRI-guided TMS therapy if:

• You continue to experience mental health or neurological symptoms despite therapy or medication
• You prefer a non-medication treatment approach
• You are looking for a non-invasive option with minimal downtime
• You want a more personalized treatment plan guided by brain imaging
• You are interested in advanced mental health care beyond standardized protocols

Candidacy is always determined through clinical evaluation rather than symptoms alone.

Who can get fMRI-guided TMS therapy?

TMS therapy may be considered for individuals experiencing conditions such as:

• Depression
• Anxiety disorders
• Obsessive-compulsive disorder (OCD)
• Post-traumatic stress disorder (PTSD)
• Bipolar-related depressive symptoms
• Certain neurological or brain injury–related conditions

At Neurotherapeutix, treatment planning begins with clinical review and functional MRI-based computational brain mapping to determine whether this approach aligns with your individual needs.

Is fMRI-guided TMS right for me? Important questions to consider

Deciding whether TMS therapy is a good fit often comes down to understanding your symptoms, treatment history, and personal goals.

These are some of the most common questions patients ask when considering whether fMRI-guided TMS therapy is appropriate for them.

How will TMS work for me?

Response varies from person to person. While many patients experience meaningful improvement, outcomes depend on factors such as symptom history, neural connectivity patterns, and overall clinical presentation.

Functional MRI-based computational brain mapping helps personalize treatment targeting, which may support more individualized care planning.

Do I need to stop medication before TMS?

Not necessarily. While many people explore TMS after trying medication or psychotherapy, treatment decisions are based on clinical evaluation rather than strict sequencing. Your care team considers your preferences, treatment history, and goals when determining next steps.

Who is not eligible for TMS?

Some individuals may not be suitable candidates for TMS therapy. Contraindications can include:

• Certain implanted metallic or electronic devices near the head
• Medical conditions that may increase seizure risk
• Other safety considerations identified during clinical evaluation

Your care team will review medical history and safety guidelines before recommending treatment.

Safety guidelines and side effects

TMS therapy is generally well-tolerated and does not require anesthesia or sedation. Common side effects are usually mild and temporary, and may include:

• Scalp discomfort during treatment
• Mild headache
• Temporary facial muscle twitching

Serious complications are rare, and safety screening is completed before treatment begins.

What to expect from fMRI-guided TMS treatment

Treatment typically follows several steps:

• Initial consultation and clinical review
• Functional MRI-based computational brain mapping
• Personalized targeting using imaging data
• A series of outpatient TMS sessions
• Ongoing monitoring and adjustments as needed

Sessions often last approximately 20–30 minutes, allowing most patients to return to normal activities afterward.

Why choose Neurotherapeutix in NYC for TMS therapy

Located on Manhattan’s Upper East Side, Neurotherapeutix is the first and only clinic in the United States to offer fMRI-guided TMS therapy using patented computational brain mapping technology.

Our physicians combine advanced neuroscience with compassionate, expert-led care designed to support brain function and strengthen neural connections through personalized treatment strategies.

Get started with fMRI-guided TMS therapy in NYC

If you are wondering whether you may be a candidate for TMS therapy, the best next step is a consultation with our team.

We take the time to understand your symptoms, treatment history, and goals so you can make informed decisions about your care.

Request an appointment or contact us directly to learn whether fMRI-guided TMS therapy may be appropriate for you.

FAQs about TMS eligibility and treatment